Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial

por Miller, Michael E., Williamson, Jeff D., Gerstein, Hertzel C., Byington, Robert P., Cushman, William C., Ginsberg, Henry N., Ambrosius, Walter T., Lovato, Laura, Applegate, William B.
Publicado 2014

Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial

por Riddle, Matthew C., Ambrosius, Walter T., Brillon, David J., Buse, John B., Byington, Robert P., Cohen, Robert M., Goff, David C., Malozowski, Saul, Margolis, Karen L., Probstfield, Jeffrey L., Schnall, Adrian, Seaquist, Elizabeth R.
Publicado 2010

Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial

por Linz, Peter E., Lovato, Laura C., Byington, Robert P., O’Connor, Patrick J., Leiter, Lawrence A., Weiss, Daniel, Force, Rex W., Crouse, John R., Ismail-Beigi, Faramarz, Simmons, Debra L., Papademetriou, Vasilios, Ginsberg, Henry N., Elam, Marshall B.
Publicado 2014

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

por Bonds, Denise E, Miller, Michael E, Bergenstal, Richard M, Buse, John B, Byington, Robert P, Cutler, Jeff A, Dudl, R James, Ismail-Beigi, Faramarz, Kimel, Angela R, Hoogwerf, Byron, Horowitz, Karen R, Savage, Peter J, Seaquist, Elizabeth R, Simmons, Debra L, Sivitz, William I, Speril-Hillen, Joann M, Sweeney, Mary Ellen
Publicado 2010